[Dilip Davda] The company enjoys niche place in building cleanrooms for pharma, healthcare and biotech sectors, including related services. It posted steady growth from FY22 to FY23, but suffered a setback following change in product mix and delayed shipments of orders. Based on its recent earnings, the issue appears fully priced. The company is likely to catch first mover fancy post listing. Investors may park funds for the medium to long term. Read detail review...

Fabtech Technologies IPO Review by Members

Fabtech Technologies IPO Reviews, analysis and views by popular members. Read Fabtech Technologies Cleanrooms Ltd. IPO reviews by retail investors to find recommended ipo to buy.

Fabtech Technologies IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%	0.00	0.00	0.00	0.00

Member	Review
No recommendation found. Be the first to post the recommendation.

Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.

Fabtech Technologies IPO Review & Recommendations

Fabtech Technologies IPO Review Summary from brokers and analysts

Fabtech Technologies IPO Review by Dilip Davda (Apply)

Fabtech Technologies IPO Review by Members

Fabtech Technologies IPO Review Summary by Members

Read more about Fabtech Technologies IPO